Log in
Enquire now
‌

US Patent 11560590 Methods and compositions for sequencing complementary polynucleotides

Patent 11560590 was granted and assigned to Singular genomics Systems, Inc. on January, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Singular genomics Systems, Inc.
Singular genomics Systems, Inc.
0
Current Assignee
Singular genomics Systems, Inc.
Singular genomics Systems, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
115605900
Patent Inventor Names
Eli N. Glezer0
Daan Witters0
Allen Lipson0
Date of Patent
January 24, 2023
0
Patent Application Number
178404900
Date Filed
June 14, 2022
0
Patent Citations
‌
US Patent 10738072 Nucleotide analogues
Patent Citations Received
‌
US Patent 11913071 Methods and compositions for sequencing complementary polynucleotides
0
Patent Primary Examiner
‌
Cynthia B Wilder
0
CPC Code
‌
C12Q 1/6834
0
‌
C12Q 1/6869
0

Disclosed herein, inter alia, are substrates, kits, and efficient methods of preparing and sequencing two or more regions of a double-stranded polynucleotide.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11560590 Methods and compositions for sequencing complementary polynucleotides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.